Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Number of holders
34
Total Shares
16.3M
Shares change
-886K
Total reported value, excl. options
$58.1M
Value change
-$3.25M
Put/Call ratio
0.58
Number of buys
11
Number of sells
-17
Price
$3.56
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.